BEAM
Price
$26.87
Change
+$1.45 (+5.70%)
Updated
Oct 15, 11:16 AM (EDT)
Capitalization
2.57B
25 days until earnings call
Intraday Buy/Sell Signals
GLPG
Price
$34.12
Change
+$0.62 (+1.85%)
Updated
Oct 15, 11:15 AM (EDT)
Capitalization
2.26B
20 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

BEAM vs GLPG

Header iconBEAM vs GLPG Comparison
Open Charts BEAM vs GLPGBanner chart's image
Beam Therapeutics
Price$26.87
Change+$1.45 (+5.70%)
Volume$3K
Capitalization2.57B
Galapagos
Price$34.12
Change+$0.62 (+1.85%)
Volume$100
Capitalization2.26B
BEAM vs GLPG Comparison Chart in %
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLPG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. GLPG commentary
Oct 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and GLPG is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 17, 2025
Stock price -- (BEAM: $25.42 vs. GLPG: $33.51)
Brand notoriety: BEAM and GLPG are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 75% vs. GLPG: 43%
Market capitalization -- BEAM: $2.57B vs. GLPG: $2.26B
BEAM [@Biotechnology] is valued at $2.57B. GLPG’s [@Biotechnology] market capitalization is $2.26B. The market cap for tickers in the [@Biotechnology] industry ranges from $105.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.02B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileGLPG’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • GLPG’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than GLPG.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 3 TA indicator(s) are bullish while GLPG’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 3 bullish, 5 bearish.
  • GLPG’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both BEAM and GLPG are a bad buy in the short-term.

Price Growth

BEAM (@Biotechnology) experienced а +1.15% price change this week, while GLPG (@Biotechnology) price change was -4.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.44%. For the same industry, the average monthly price growth was +17.42%, and the average quarterly price growth was +81.94%.

Reported Earning Dates

BEAM is expected to report earnings on Nov 10, 2025.

GLPG is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+0.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.57B) has a higher market cap than GLPG($2.26B). GLPG YTD gains are higher at: 21.836 vs. BEAM (2.500). GLPG has higher annual earnings (EBITDA): -225.76M vs. BEAM (-414.33M). GLPG has more cash in the bank: 3.09B vs. BEAM (1.15B). GLPG has less debt than BEAM: GLPG (8.44M) vs BEAM (155M). GLPG has higher revenues than BEAM: GLPG (276M) vs BEAM (60.3M).
BEAMGLPGBEAM / GLPG
Capitalization2.57B2.26B114%
EBITDA-414.33M-225.76M184%
Gain YTD2.50021.83611%
P/E RatioN/A53.70-
Revenue60.3M276M22%
Total Cash1.15B3.09B37%
Total Debt155M8.44M1,836%
FUNDAMENTALS RATINGS
GLPG: Fundamental Ratings
GLPG
OUTLOOK RATING
1..100
80
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
45
P/E GROWTH RATING
1..100
58
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMGLPG
RSI
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
68%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
66%
Momentum
ODDS (%)
N/A
Bearish Trend 3 days ago
74%
MACD
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
74%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
55%
Advances
ODDS (%)
Bullish Trend 8 days ago
78%
Bullish Trend 14 days ago
61%
Declines
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 3 days ago
76%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
77%
Aroon
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 3 days ago
40%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLPG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MCVRX30.60N/A
N/A
MFS Mid Cap Value R2
HRLSX9.72N/A
N/A
Hartford Real Asset R4
VIPAX29.26N/A
N/A
Voya Index Plus LargeCap Port ADV
IAVGX21.85N/A
N/A
Voya Growth and Income Port A
TLCYX20.50N/A
N/A
Touchstone Large Cap Y

GLPG and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLPG has been loosely correlated with VCYT. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if GLPG jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLPG
1D Price
Change %
GLPG100%
-1.22%
VCYT - GLPG
43%
Loosely correlated
-0.41%
BEAM - GLPG
39%
Loosely correlated
+0.12%
NTLA - GLPG
38%
Loosely correlated
+0.57%
AXON - GLPG
35%
Loosely correlated
-0.75%
CRSP - GLPG
35%
Loosely correlated
+1.60%
More